Keywords: novexel, nxl104, enters, ph, testing, paris, france-based

Novexel's NXL104 enters Ph I testing

Article | 22 December 2006

Print This

Paris, France-based Novexel says that its beta-lactamase inhibitor, NXL104, has advanced into Phase I clinical testing. The firm noted that ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in